Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: results from an 18-year longitudinal dataset

OBJECTIVES: The clinical benefit of conventional disease-modifying antirheumatic drugs (cDMARDs) for treating ankylosing spondylitis (AS) is generally limited to improvements in peripheral arthritis. However, cDMARDs could be conditionally considered as alternatives to established drugs for improvin...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ther Adv Musculoskelet Dis
Glavni autori: Lee, Tae-Han, Koo, Bon San, Nam, Bora, Oh, Ji Seon, Park, Seo Young, Lee, Seunghun, Joo, Kyung Bin, Kim, Tae-Hwan
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2020
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705797/
https://ncbi.nlm.nih.gov/pubmed/33294039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20975912
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items